Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
gptkb:Semaxanib
|
| gptkbp:CASNumber |
191732-72-6
|
| gptkbp:developedBy |
gptkb:receptor_tyrosine_kinase
|
| gptkbp:developer |
gptkb:Sugen
|
| gptkbp:hasMolecularFormula |
C22H19FN4O3
|
| gptkbp:investigatedBy |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
inhibits angiogenesis
|
| gptkbp:status |
discontinued
|
| gptkbp:target |
gptkb:VEGFR-2
|
| gptkbp:bfsParent |
gptkb:Burcot,_Oxfordshire,_England
gptkb:Clifton_Hampden |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
SU5494
|